Industry Bulletins | August 24, 2016
NeuroCog Trials Receives $2 Million Grant From The National Institute Of Mental Health
NeuroCog Trials, Inc., a cognitive services provider for the clinical trials industry has announced that it has been awarded a Phase IIB grant from the Small Business Innovation Research (SBIR) program of the National Institute of Mental Health (NIMH) to collect additional normative data and internationalize the Virtual Reality Functional Capacity Assessment Tool or VRFCAT©. The 3-year project builds on the successful Phase I and II grants that funded the development of the VRFCAT and validation in patients with schizophrenia and healthy controls. The VRFCAT is a computerized measure that was developed to be a reliable, valid, and sensitive . . .